IDR 246.0
(2.5%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1488.19 Billion IDR | -10.28% |
2022 | 1658.68 Billion IDR | -3.04% |
2021 | 1710.75 Billion IDR | 49.0% |
2020 | 1148.14 Billion IDR | 18.99% |
2019 | 964.89 Billion IDR | 13.22% |
2018 | 852.23 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 413.75 Billion IDR | 6.26% |
2024 Q2 | 370.73 Billion IDR | -10.4% |
2024 Q3 | 372.46 Billion IDR | 0.47% |
2023 Q3 | 377.05 Billion IDR | 12.12% |
2023 FY | 1488.19 Billion IDR | -10.28% |
2023 Q4 | 389.39 Billion IDR | 3.27% |
2023 Q2 | 336.31 Billion IDR | -12.74% |
2023 Q1 | 385.43 Billion IDR | -10.37% |
2022 Q2 | 426 Billion IDR | 9.54% |
2022 Q1 | 388.89 Billion IDR | 0.28% |
2022 FY | 1658.68 Billion IDR | -3.04% |
2022 Q4 | 430.02 Billion IDR | 3.93% |
2022 Q3 | 413.75 Billion IDR | -2.88% |
2021 Q2 | 451.96 Billion IDR | 0.39% |
2021 Q4 | 387.79 Billion IDR | -7.84% |
2021 Q3 | 420.78 Billion IDR | -6.9% |
2021 Q1 | 450.21 Billion IDR | 34.47% |
2021 FY | 1710.75 Billion IDR | 49.0% |
2020 FY | 1148.14 Billion IDR | 18.99% |
2020 Q1 | 232.3 Billion IDR | 0.0% |
2020 Q4 | 334.79 Billion IDR | -4.0% |
2020 Q3 | 348.73 Billion IDR | 50.12% |
2020 Q2 | 232.3 Billion IDR | 0.0% |
2019 FY | 964.89 Billion IDR | 13.22% |
2018 FY | 852.23 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -513.232% |
PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 74.271% |
PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | 65.101% |
PT Murni Sadar Tbk | 921.91 Billion IDR | -61.425% |
PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | 19.086% |
PT Royal Prima Tbk | 265.33 Billion IDR | -460.871% |
PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -298.553% |
PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | 3.089% |
PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 86.701% |
PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | 40.548% |